COWEALTH MEDICAL

Explore how Cowealth Medical China’s medical‑equipment business and market volatility are intertwined, and what investors can do to navigate regulatory and liquidity risks.

合富中国股价连涨停9天，年内涨幅129%，成交额18亿元创三年新高；但2025年营收下滑24%，市盈率-327，已被列入严重异动名单。了解最新走势与风险。

最新Cowealth Medical China（603122）股价与业务概览：了解其医疗设备业务、财务数据及投资者关注点。

Discover how Cowealth Medical’s growth‑oriented strategy and new MRI‑guided radiotherapy line could boost its 2025 revenue and earnings, making it a promising pick for med‑tech investors.

Investors beware: Cowealth Medical China remains loss‑making, its 61% spike is driven by speculation, not fundamentals, and a quick correction is likely.

Discover why Cowealth Medical China’s Q1 earnings miss sparked a 46.5% stock rally amid market‑wide health‑tech momentum and AI‑driven growth prospects.